Read our Privacy noticeA new daily weight loss pill, made by the same pharmaceutical company that makes the Mounjaro jab has been approved for use in the UK. The Eli Lilly pill is the second GLP-1 oral pill approved for use in the UK after Novo’s Wegovy pill in June, but it won’t yet be available on the NHS. Here, The Independent breaks down everything you need to know about the new weight loss pills. Orforglipron, sold as Foundayo, is a type of weight loss drug, also known as a GLP-1 receptor agonist. Unlike Novo’s Wegovy pill, Foundayo will only be available privately.